Clinical Trials
Clinical Trials : Mitochondrial Diseases

Search for Clinical Trial Results

Sponsored By

Mitochondrial Diseases - 22 Studies Found

Status	Study
Terminated	Study Name: Anesthetic Effects in Mitochondrial Disease Condition: Mitochondrial Disease Date: 2009-10-21 Interventions: Drug: sevoflurane During induction, concentration of inspired sevoflurane will begin at .5%, and slowly
Completed	Study Name: Glycemic Index in Mitochondrial Disease Condition: Mitochondrial Diseases Date: 2014-10-21 Interventions: Other: test meal low- or high-glycemic index test meal, administered during mixed meal tolerance test
Recruiting	Study Name: Anesthesia in Patients With Mitochondrial Disease Condition: Mitochondrial Diseases Date: 2014-01-31 Interventions: Drug: Sevoflurane Sevoflurane
Recruiting	Study Name: Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease Condition: Mitochondrial Disease Date: 2014-05-29
Completed	Study Name: Phase III Trial of Coenzyme Q10 in Mitochondrial Disease Condition: Mitochondrial Diseases Date: 2007-02-06 Interventions: Drug: CoenzymeQ10 CoenzymeQ10
Enrolling by invitation	Study Name: Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Disease (PMD) Condition: Primary Mitochondrial Disease Date: 2016-11-18 Interventions: Drug: elamipretide 40 mg, subcutaneous injections (in the abdomen) daily for the shortest of the followi
Completed	Study Name: Survey on Supplement Use in Mitochondrial Disease Condition: Mitochondrial Disease Date: 2014-09-12
Active, not recruiting	Study Name: Calf Muscle Strength in Mitochondrial Diseases Condition: Mitochondrial Disease Date: 2016-02-03 Interventions: Other: MRI and muscle dynamometer
Recruiting	Study Name: The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases Condition: Mitochondrial Diseases Date: 2016-06-15 Interventions: Dietary Supplement: Arginine A
Terminated	Study Name: RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease Condition: Mitochondrial Diseases Date: 2003-05-07 Interventions: Drug: RG2133 (2',3',5'-tri-O-acetyluridine)